Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Beguin

Showing results (81-90 of 242) with videos related to

Pageof 25
Sort By:
Cell Biology International|March 2, 2010
The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord bloodMustapha Zeddou, Alexandra Briquet, Biserka Relic, et al.
Cancer Immunology, Immunotherapy : CII|May 15, 2015
Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantationMarilène Binsfeld, Muriel Hannon, Eléonore Otjacques, et al.
Blood|March 6, 2002
Increased binding and defective migration across fibronectin of cycling hematopoietic progenitor cellsOlivier Giet, Dirk R Van Bockstaele, Ivano Di Stefano, et al.
Acta Clinica Belgica|April 15, 2016
Yellow nail syndrome after allogeneic haematopoietic stem cell transplantation in two patients with multiple myelomaCéline Gregoire, Julien Guiot, Gaëlle Vertenoeil, et al.
Stem Cells and Development|November 18, 2011
Differential signalling through ALK-1 and ALK-5 regulates leptin expression in mesenchymal stem cellsMustapha Zeddou, Biserka Relic, Olivier Malaise, et al.
World Journal of Gastroenterology|July 30, 2011
Liver transplantation for acute hepatic failure due to chemotherapy-induced HBV reactivation in lymphoma patientsTimothée Noterdaeme, Luc Longrée, Christian Bataille, et al.
Plos One|February 26, 2013
Kinetics of IL-7 and IL-15 levels after allogeneic peripheral blood stem cell transplantation following nonmyeloablative conditioningMuriel De Bock, Marianne Fillet, Muriel Hannon, et al.
American Journal of Hematology|June 27, 2015
Erythropoietin therapy after allogeneic hematopoietic cell transplantation has no impact on long-term survivalAurélie Jaspers, Frédéric Baron, Sophie Servais, et al.
Pharmaceutics|February 28, 2020
Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial DataGils Roex, Tom Feys, Yves Beguin, et al.
Plos One|May 14, 2013
Mithramycin exerts an anti-myeloma effect and displays anti-angiogenic effects through up-regulation of anti-angiogenic factorsEléonore Otjacques, Marilène Binsfeld, Natacha Rocks, et al.
Pageof 25

Showing results (81-90 of 242) with videos related to

Sort By:
Pageof 25
Cell Biology International|March 2, 2010
The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord bloodMustapha Zeddou, Alexandra Briquet, Biserka Relic, et al.
Cancer Immunology, Immunotherapy : CII|May 15, 2015
Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantationMarilène Binsfeld, Muriel Hannon, Eléonore Otjacques, et al.
Blood|March 6, 2002
Increased binding and defective migration across fibronectin of cycling hematopoietic progenitor cellsOlivier Giet, Dirk R Van Bockstaele, Ivano Di Stefano, et al.
Acta Clinica Belgica|April 15, 2016
Yellow nail syndrome after allogeneic haematopoietic stem cell transplantation in two patients with multiple myelomaCéline Gregoire, Julien Guiot, Gaëlle Vertenoeil, et al.
Stem Cells and Development|November 18, 2011
Differential signalling through ALK-1 and ALK-5 regulates leptin expression in mesenchymal stem cellsMustapha Zeddou, Biserka Relic, Olivier Malaise, et al.
World Journal of Gastroenterology|July 30, 2011
Liver transplantation for acute hepatic failure due to chemotherapy-induced HBV reactivation in lymphoma patientsTimothée Noterdaeme, Luc Longrée, Christian Bataille, et al.
Plos One|February 26, 2013
Kinetics of IL-7 and IL-15 levels after allogeneic peripheral blood stem cell transplantation following nonmyeloablative conditioningMuriel De Bock, Marianne Fillet, Muriel Hannon, et al.
American Journal of Hematology|June 27, 2015
Erythropoietin therapy after allogeneic hematopoietic cell transplantation has no impact on long-term survivalAurélie Jaspers, Frédéric Baron, Sophie Servais, et al.
Pharmaceutics|February 28, 2020
Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial DataGils Roex, Tom Feys, Yves Beguin, et al.
Plos One|May 14, 2013
Mithramycin exerts an anti-myeloma effect and displays anti-angiogenic effects through up-regulation of anti-angiogenic factorsEléonore Otjacques, Marilène Binsfeld, Natacha Rocks, et al.
Pageof 25